Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 107-128
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.107
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Study design.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 The composition of gut microbiota [relative abundance (%) in the probiotic-treated and placebo groups before and after ingestion period].
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 The phylum distribution composition of each subject from both probiotic-treated and placebo groups. The number on the X-axis represents the code of subject.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 The changes in phylum of bacterial composition in both probiotic-treated and placebo groups before and after ingestion period. PRO1: Probiotic before ingestion; PRO2: Probiotic after ingestion; PLC1: Placebo before ingestion; PLC2: Placebo after ingestion.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Cladogram and Alpha diversity on the treatment group and placebo group before and after the ingestion period. PRO1: Probiotic before ingestion; PRO2: Probiotic after ingestion; PLC1: Placebo before ingestion; PLC2: Placebo after ingestion.
  • Citation: Rahayu ES, Mariyatun M, Putri Manurung NE, Hasan PN, Therdtatha P, Mishima R, Komalasari H, Mahfuzah NA, Pamungkaningtyas FH, Yoga WK, Nurfiana DA, Liwan SY, Juffrie M, Nugroho AE, Utami T. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol 2021; 27(1): 107-128
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i1/107.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i1.107